Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time
The clinicopathological breast cancer subtypes are used in clinical practice to better anticipate biological behaviour and guide systemic treatment strategy. In the adjuvant setting, genomic assay recurrence scores became widely available for luminal-like disease. Recently, next-generation sequencin...
Main Authors: | Marta Vaz Batista, Diogo Alpuim Costa, Paula Borralho, Sofia Braga |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-08-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/517441 |
Similar Items
-
Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice
by: Simona Bruzas, et al.
Published: (2021-09-01) -
Landscape of circulating tumour DNA in metastatic breast cancer
by: Andrew A. Davis, et al.
Published: (2020-08-01) -
The Experience of Young Women Living with Advanced Breast Cancer: A Hermeneutic Phenomenological Study
by: Lundquist, Debra
Published: (2018) -
DECODING THE TRANSCRIPTIONAL LANDSCAPE OF TRIPLE-NEGATIVE BREAST CANCER USING NEXT GENERATION WHOLE TRANSCRIPTOME SEQUENCING
by: Radovich, Milan
Published: (2012) -
Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions
by: Toshiaki Akahane, et al.
Published: (2020-10-01)